Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the immunogenicity and efficacy of HBsAg Vaccine in
combination with Entecavir in patients who have been treated with HB110E HBV DNA vaccine.